We’ve compiled the most relevant results based on your search. Please review the listings below to find what best meets your needs.
If you don’t see what you’re looking for, consider refining your search or adjusting the filters or using the form below to contact us.
Two-thirds of U.S. adults use prescription drugs, with older adults and those with chronic conditions accounting for most usage. Rising medication use and technological advances have driven up costs, sometimes leading patients to underuse prescriptions. This article examines the role of demographics, chronic illness, and policy in medication compliance.
This article explores cost-effective methods for treating and disposing of regulated medical waste (RMW), based on findings from three Massachusetts hospitals. It highlights proper waste sorting and the combined use of on-site incineration and microwaving. The study also recommends standardized classification into four categories to improve efficiency and cost savings.
This study examines the economic cost of opioid use disorder (OUD) and the societal value of preventing it. Using 2015–2018 data, it analyzes the financial burden across taxpayers, healthcare, and society, revealing increased spending despite a decline in OUD cases—largely due to the rising prevalence of fentanyl.
In 2020, the U.S. opioid crisis cost nearly $1.5 trillion, fueled by increased use and overdose deaths during the COVID-19 pandemic. Disruptions in care and rising racial disparities, particularly among Black Americans, worsened outcomes. The findings highlight the need for expanded treatment access, stigma reduction, and sustained public health efforts.